BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Corixa Corporation 

1900 9th Avenue, Suite 1100

Seattle  Washington  98101  U.S.A.
Phone: 206-366-3700 Fax: 206-366-4700


SEARCH JOBS
Corixa is a biopharmaceutical company developing oncology and immunology products that manage human diseases. On June 30, 2003, Corixa announced that the FDA approved BEXXAR for the treatment of patients with CD20 positive,
follicular, NHL, with and without transformation, whose disease is refractory to Rituximab and has relapsed following chemotherapy.

Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. In addition
to BEXXAR, Corixa currently has multiple programs in clinical development, including several product candidates that have advanced to and through late stage clinical trials. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are Powered by
Corixa(tm) technology with the goal of making its potential products available to patients around the world. Corixa was founded in 1994 and is headquartered in Seattle, with additional operations in Hamilton, Mont., and South San Francisco. For more information, please visit Corixa's Web site at www.corixa.com.

Management

  • Steven Gillis, Ph.D., Chairman and Chief Executive Officer
  • Michelle Burris, Senior Vice President and Chief Financial Officer
  • David Fanning, Senior Vice President and Chief Operating Officer


Last Updated: 10-18-04


 Key Statistics


Email: info@corixa.com
Ownership: Public

Web Site: Corixa Corporation
Employees: 400
Symbol: CRXA
 



Industry
Biotechnology


Collaborations

Incyte Corporation 

Genesis Research and Development Corporation 

Gen-Probe Incorporated (Acquired by Hologic)  In January 2005, Gen-Probe signed an agreement with Corixa to license rights to develop molecular diagnostic tests for approximately 50 potential genetic markers in the areas of prostate, ovarian, cervical, kidney, lung and colon cancer.

GlaxoSmithKline (North Carolina) 





 Company News
PanBio Limited (PBO.AX) Purchases Intellectual Property From Corixa Corporation (CRXA) For Detecting Tick Borne Diseases 10/19/2005 5:13:16 PM    More...
Corixa Corporation (CRXA) To Present At Lehman Brothers Global Healthcare Conference 10/19/2005 5:13:09 PM    More...
Corixa Corporation (CRXA) To Present At Invest Northwest Life Sciences Conference 10/19/2005 5:13:02 PM    More...
Corixa Corporation (CRXA) Announces Fourth Quarter And Year-End 2004 Financial Results 10/19/2005 5:13:00 PM    More...
Conference Call/Webcast Alert: Corixa Corporation (CRXA) Fourth Quarter And Year End 2004 Earnings Conference Call 10/19/2005 5:12:54 PM    More...
Corixa Corporation (CRXA) And Lorantis Announce Joint Collaboration To Develop Therapeutic Hepatitis B Vaccine 10/19/2005 5:12:54 PM    More...
New Era For Biotech? 10/19/2005 5:12:40 PM    More...
Corixa Corporation (CRXA) Announces European Approval For Fendrix, GlaxoSmithKline Biologicals' (GSK) Hepatitis B Vaccine Containing Corixa's MPL Adjuvant 10/19/2005 5:12:39 PM    More...
Lymphoma Treatment Shows Promise 10/19/2005 5:12:37 PM    More...
Genitope Corporation (GTOP) Adds To Operating Management Team 10/19/2005 5:12:34 PM    More...
1234567

//-->